OS benefit observed across key subgroups, including patients with high tumor burden, elevated LDH, and extrahepatic disease as well as…

On April 10, 2026, the U.S. Food and Drug Administration (FDA) issued a decision not to approve the resubmission of…

We are proud to share that burnd Sunscreen has joined AIM at Melanoma as our 2026 National Sunscreen Partner. This…

In this episode of Beyond the Clinic: Living Well with Melanoma, host Dr. Samantha Siegel sits down with Dr. Victoria…

Presented in partnership with Save Your Skin Foundation and Ocumel CanadaOcumel Canada (OC), is powered by Save Your Skin Foundation,…

A Diagnosis That Changed Everything In early 2021, Wade Watson and his father received life-changing news just weeks apart. His…

As the U.S. Food and Drug Administration approaches a pivotal decision on a potential new treatment for advanced melanoma, patient…

Cancer is often spoken about in terms of diagnosis, treatment plans, and survival rates. But there is a quieter, more…

San Diego, CA & Rotterdam, Netherlands- February 19, 2026 — SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its…

As part of our continued advocacy for patients with advanced melanoma, we are sharing the U.S. Food and Drug Administration’s…